Former Gilead Sciences Executive Amy E. Flood Joins Corcept Therapeutics as Chief Human Resources and Communications Officer

NEXT STORY
Numi Health Launches Mobile Intravenous Nutrient Therapy
PREV STORY
Summit Therapeutics Presents Breakthrough Research Data from Phase II Studies, including Evidence Validating Microbiome Preservation, for its Investigational Drug Ridinilazole
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Emergent BioSolutions to Release First Quarter 2016 Financial Results and Conduct a Conference Call on May 5, 2016

GAITHERSBURG, Md., April 21, 2016 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will host ...

author_avatar
NASDAQ Market News

Midatech Announces Interim Results from Proof of Concept Exploratory Study for its MTD201 Q-Octreotide Programme and Q-Sphera™ Microsphere Technology

­­31 August 2018 Midatech Pharma PLC("Midatech" or the "Company") Midatech Announces Interim Results from ...

author_avatar
NASDAQ Market News

Global ICU Beds Market accounted USD 3.7 Billion in 2019 and is expected to grow with a CAGR of 4.3% during the forecast period – PMI

author_avatar
NASDAQ Market News